Sergio Rojter

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis†

Marc G. Ghany, Brick Ayola, Federico Villamil et al. · Hepatology · 1998 · 325 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial

Keyur Patel, Stephen A. Harrison, Magdy Elkhashab et al. · Hepatology · 2020 · 321 citations

Medicine, Pharmacology, Pharmacotherapy +17

Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1‐infected patients without cirrhosis: OPTIMIST‐1, a phase 3, randomized study

Paul Y. Kwo, Norman Gitlin, Ronald Nahass et al. · Hepatology · 2016 · 189 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis

Marlyn J. Mayo, Elizabeth J. Carey, Helen T. Smith et al. · Digestive Diseases and Sciences · 2022 · 70 citations · Full text

Medicine, Internal Medicine, Hepatology +16

LP14 : A phase 3, randomised, open-label study to evaluate the efficacy and safety of 8 and 12 weeks of simeprevir (SMV) plus sofosbuvir (SOF) in treatment-naïve and -experienced patients with chronic HCV genotype 1 infection without cirrhosis: Optimist-1

Paul Y. Kwo, Norman Gitlin, Ronald Nahass et al. · Journal of Hepatology · 2015 · 67 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14